Skip To Main Content
David Armstrong on Muck Rack

David Armstrong

As seen in: Salon, The Minnesota Star Tribune, Baltimore Sun, Medscape, Miami Herald, Pioneer Press, Las Vegas Sun, MDEdge, Popular Resistance, HealthLeaders and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with David

Contact David, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

The Dressing That Talks Back

|
By David Armstrong
| Medscape Verified
I recently attended the Malvern Diabetic Foot Conference in the UK, which marked the 40th anniversary of the first international meeting on the topic. Four decades on, and we are still arguing about how to best assess a diabetic foot wound. Most of the time, we look at it the same way our forebears did: Peel back the gauze, eyeball the wound bed, smell the air, swab if we are nervous.
Open in Who Shared Issue with article?

Don't Stop Gliflozin: Study Suggests SGLT2 Inhibitors Are Safe, Possibly Beneficial in Diabetic Foot Ulcers

|
By David Armstrong
| Medscape Verified
Here's a clinical scenario every diabetologist and surgeon has faced: A patient with type 2 diabetes, heart failure, and stage 3 chronic kidney disease walks — or wheels — into your clinic with a new foot ulcer. They're on an SGLT2 inhibitor, one of the most consequential drug classes we've added to our toolkit in the past decade. You know it's protecting their heart and kidneys. But international guidelines tell you to stop it because of the foot ulcer. You hesitate.
Open in Who Shared Issue with article?

Negative Pressure Wound Therapy in Limb Preservation

|
By David Armstrong
| Medscape Verified
In limb preservation — particularly in the diabetic foot — negative pressure wound therapy (NPWT) has proven to be one of the rare technologies that can legitimately be called transformative. When it emerged in the early 2000s, it offered something clinicians had long lacked: a reliable way to control exudate, reduce wound complexity, and promote granulation in challenging wounds. But like many powerful tools, its impact depends entirely on how and when it is used.
Open in Who Shared Issue with article?
See all 30 licensed articles (40 Total)